Cathay International Holdings Limited (CTI.L) (CTI) Share Price, News & Analysis

Company Overview

Cathay International Holdings Limited, an investment holding company, invests and operates in the healthcare sector in the People's Republic of China. It operates through five segments: Lansen, Haizi, Natural Dailyhealth, Botai, and Hotel Operations. The Lansen segment manufactures, markets, and sells pharmaceuticals, cosmeceutical products, plant extracts, and healthcare products. This segment focuses on the rheumatic specialty prescription western pharmaceuticals for the treatment of autoimmune rheumatic diseases and dermatology indications; develops, manufactures, and distributes rheumatic drugs; and sells diagnostic kits and cosmeceutical products. The Haizi segment manufactures, markets, and sells inositol and phosphate related products. The Natural Dailyhealth segment provides plant extracts, such as bilberry, ginkgo extract, and ginseng extract for use as ingredients in health products. The Botai segment produces and sells collagen injectable fillers; and develops collagen related products. The Hotel Operations segment owns and operates The Crowne Plaza Hotel and Suites Landmark Shenzhen, a 5-star hotel located in the Lowu district of Shenzhen in the People's Republic of China. This segment's hotel consists of 312 rooms and suites, and banquet and meeting facilities. Cathay International Holdings Limited is based in Central, Hong Kong.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 1,030 shs
• Average Volume: 151,589 shs
• Market Capitalization: £14.35 million
• P/E Ratio: 3.75
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: N/A
• Industry: Drug Manufacturers - Major
• Sub-Industry: N/A
• Current Symbol: LON:CTI
• CIK: N/A
• Web: www.cathay-intl.com.hk
• Phone: +85228289289
• Fax: N/A
• Employees: 1,300
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 3.75
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 49.62
• Current Ratio: 1.64
• Quick Ratio: 1.46

Sales & Book Value

• Annual Sales: £76.68 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 0.09
• Book Value: GBX 7.70 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 1,913,810,048
• Free Float: N/A
• Market Cap: £14.35 million
• Optionable: Not Optionable
• Beta: N/A